Yu JS - Search Results

1

Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma.

Phuphanich S, Wheeler CJ, Rudnick JD, Mazer M, Wang H, Nuño MA, Richardson JE, Fan X, Ji J, Chu RM, Bender JG, Hawkins ES, Patil CG, Black KL, Yu JS. Phuphanich S, et al. Among authors: yu js. Cancer Immunol Immunother. 2013 Jan;62(1):125-35. doi: 10.1007/s00262-012-1319-0. Epub 2012 Jul 31. Cancer Immunol Immunother. 2013. PMID: 22847020 Free PMC article. Clinical Trial.

2

Immunotherapy of malignant brain tumors in children and adults: from theoretical principles to clinical application.

Zeltzer PM, Moilanen B, Yu JS, Black KL. Zeltzer PM, et al. Among authors: yu js. Childs Nerv Syst. 1999 Oct;15(10):514-28. doi: 10.1007/s003810050540. Childs Nerv Syst. 1999. PMID: 10550583 Review.

3

Glioblastoma induction after radiosurgery for meningioma.

Yu JS, Yong WH, Wilson D, Black KL. Yu JS, et al. Lancet. 2000 Nov 4;356(9241):1576-7. doi: 10.1016/S0140-6736(00)03134-2. Lancet. 2000. PMID: 11075777

4

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL. Yu JS, et al. Cancer Res. 2001 Feb 1;61(3):842-7. Cancer Res. 2001. PMID: 11221866 Clinical Trial.

5

A herpes simplex virus type 1 mutant deleted for gamma34.5 and LAT kills glioma cells in vitro and is inhibited for in vivo reactivation.

Samoto K, Perng GC, Ehtesham M, Liu Y, Wechsler SL, Nesburn AB, Black KL, Yu JS. Samoto K, et al. Among authors: yu js. Cancer Gene Ther. 2001 Apr;8(4):269-77. doi: 10.1038/sj.cgt.7700306. Cancer Gene Ther. 2001. PMID: 11393279

6

A herpes simplex virus type 1 mutant with gamma 34.5 and LAT deletions effectively oncolyses human U87 glioblastomas in nude mice.

Samoto K, Ehtesham M, Perng GC, Hashizume K, Wechsler SL, Nesburn AB, Black KL, Yu JS. Samoto K, et al. Among authors: yu js. Neurosurgery. 2002 Mar;50(3):599-605; discussion 605-6. doi: 10.1097/00006123-200203000-00031. Neurosurgery. 2002. PMID: 11841729

7

In situ adenoviral interleukin 12 gene transfer confers potent and long-lasting cytotoxic immunity in glioma.

Liu Y, Ehtesham M, Samoto K, Wheeler CJ, Thompson RC, Villarreal LP, Black KL, Yu JS. Liu Y, et al. Among authors: yu js. Cancer Gene Ther. 2002 Jan;9(1):9-15. doi: 10.1038/sj.cgt.7700399. Cancer Gene Ther. 2002. PMID: 11916248

8

The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma.

Ehtesham M, Kabos P, Kabosova A, Neuman T, Black KL, Yu JS. Ehtesham M, et al. Among authors: yu js. Cancer Res. 2002 Oct 15;62(20):5657-63. Cancer Res. 2002. PMID: 12384520

9

Treatment of intracranial glioma with in situ interferon-gamma and tumor necrosis factor-alpha gene transfer.

Ehtesham M, Samoto K, Kabos P, Acosta FL, Gutierrez MA, Black KL, Yu JS. Ehtesham M, et al. Among authors: yu js. Cancer Gene Ther. 2002 Nov;9(11):925-34. doi: 10.1038/sj.cgt.7700516. Cancer Gene Ther. 2002. PMID: 12386831

10

Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.

Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, Yu JS. Ehtesham M, et al. Among authors: yu js. Cancer Res. 2002 Dec 15;62(24):7170-4. Cancer Res. 2002. PMID: 12499252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,469 results

Search Page